Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07640555 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies

Study acronym: MODAG-009-P1-0
StatusRecruiting
PhaseEarly Phase 1
SponsorMODAG GmbH
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is a single-center, open-label clinical study designed to evaluate the imaging characteristics and safety of \[¹⁸F\]MODAG-009 in participants with Parkinson's disease (PD), Multiple system atrophy (MSA), and Healthy controls (HC). Approximately 13 participants will be enrolled in this study. Each participant will receive a single intravenous injection of \[¹⁸F\]MODAG-009, followed by PET imaging using the investigational United Imaging NeuroEXPLORER (NX) camera.
Trial Details
NCT Number NCT07640555
Lead Sponsor MODAG GmbH
Collaborators: XingImaging, LLC, Institute for Neurodegenerative Disorders
Conditions
(from sponsor)		 Multiple System Atrophy (MSA), Healthy Adult, Parkinson Disease
Related terms Multiple System Atrophy, Parkinson Disease
Enrollment 13 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov